CSIMarket
 


Painreform Ltd  (PRFX)
Other Ticker:  
 
 

PRFX's Income from Cont. Operations Growth by Quarter and Year

Painreform Ltd's Income from Cont. Operations results by quarter and year




PRFX Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December -8.79 -7.25 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -8.79 -7.25 0.00 0.00



PRFX Income from Cont. Operations fourth quarter 2022 Y/Y Growth Comment
Painreform Ltd in the fourth quarter 2022 recorded loss from continued operations of $ -8.79 millions.

According to the results reported in the fourth quarter 2022, Painreform Ltd achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Painreform Ltd' s Income from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2022.




PRFX Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Painreform Ltd's fourth quarter 2022 Income from Cont. Operations $ -8.79 millions PRFX's Income Statement
Painreform Ltd's fourth quarter 2021 Income from Cont. Operations $ -7.25 millions Quarterly PRFX's Income Statement
New: More PRFX's historic Income from Cont. Operations Growth >>


PRFX Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Painreform Ltd's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRFX's IV. Quarter Q/Q Income from Cont. Operations Comment


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRFX's IV. Quarter Q/Q Income from Cont. Operations Comment


Painreform Ltd's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
0
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ -8.79 $ 0.00 $ 0.00 $ 0.00 $ -7.25
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Painreform Ltd' has realized cumulative trailing twelve months loss from continued operations of $ -9 millions in the Dec 31 2022 period.
The business is worsening as the cumulative loss from continued operations is getting bigger from $ -7.25 millions in the twelve months ending a quarter before and $ millions for the twelve months ending in the quarter Dec 31 2021 Florentina Costa mentioned.

Painreform Ltd achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Painreform Ltd' has realized cumulative trailing twelve months loss from continued operations of $ -9 millions in the Dec 31 2022 period.
The business is getting worse as the cumulative loss from continued operations is getting bigger from $ -7.25 millions in TTM ending quarter 0 and $ millions from the TTM period ending Dec 31 2021 Florentina Costa mentioned.

Painreform Ltd achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
PRFX's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for PRFX's Competitors
Income from Cont. Operations Growth for Painreform Ltd's Suppliers
Income from Cont. Operations Growth for PRFX's Customers

You may also want to know
PRFX's Annual Growth Rates PRFX's Profitability Ratios PRFX's Asset Turnover Ratio PRFX's Dividend Growth
PRFX's Roe PRFX's Valuation Ratios PRFX's Financial Strength Ratios PRFX's Dividend Payout Ratio
PRFX's Roa PRFX's Inventory Turnover Ratio PRFX's Growth Rates PRFX's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2022
Charles River Laboratories International inc 35.24%$ 35.243 millions
Dr Reddy s Laboratories Limited31.78%$ 31.780 millions
Vericel Corporation30.58%$ 30.584 millions
Elite Pharmaceuticals Inc 30.07%$ 30.072 millions
Pfizer Inc29.93%$ 29.930 millions
Bruker Corporation29.34%$ 29.342 millions
Cadre Holdings inc 24.37%$ 24.369 millions
Alpha Tau Medical Ltd 23.80%$ 23.802 millions
Ensign Group Inc23.61%$ 23.607 millions
Neurocrine Biosciences Inc 22.25%$ 22.253 millions
Staar Surgical Company18.92%$ 18.915 millions
Edwards Lifesciences Corporation18.82%$ 18.819 millions
Purple Biotech Ltd 17.83%$ 17.825 millions
United Therapeutics Corporation17.74%$ 17.736 millions
Integra Lifesciences Holdings Corp16.66%$ 16.662 millions
Electromed Inc 16.59%$ 16.587 millions
Mettler Toledo International Inc15.14%$ 15.144 millions
Option Care Health Inc 14.98%$ 14.979 millions
Addus Homecare Corporation13.05%$ 13.049 millions
Eli Lilly And Company12.26%$ 12.259 millions
Resmed Inc 11.48%$ 11.481 millions
Zoetis Inc 11.38%$ 11.380 millions
Check cap Ltd 11.08%$ 11.080 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com